{"id":"W1971546178","doi":"10.1038/sj.bjc.6601478","title":"Quality-of-life benefits and evidence of antitumour activity for patients with brain metastases treated with gefitinib","year":2003,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"The Scarborough Hospital","funders":"","keywords":"Gefitinib; Medicine; Oncology; Radiation therapy; Chemotherapy; Quality of life (healthcare); Lung cancer; Internal medicine; Brain metastasis; Clinical trial; Epidermal growth factor receptor; Cancer; Metastasis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002954213,0.0002403917,0.002060857,0.0001366724,0.00005323601,0.00002352409,0.00007237001,0.00008305043,0.00003130675],"category_scores_gemma":[0.0002776945,0.000167733,0.0002562669,0.0002356498,0.0001109227,0.0002124742,0.000009617792,0.0001785273,7.877211e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001304487,"about_ca_system_score_gemma":0.001595641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006569197,"about_ca_topic_score_gemma":0.0004538362,"domain_scores_codex":[0.9982863,0.0001408478,0.0007527218,0.0002109143,0.0004388923,0.0001702878],"domain_scores_gemma":[0.9963444,0.0004298896,0.001967601,0.0001275007,0.000960738,0.0001698705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0008037125,0.0004203179,0.01109044,0.01756512,0.002610967,0.00003092385,0.00002207019,0.000004631515,0.000001222368,0.00001516013,0.0002821739,0.9671533],"study_design_scores_gemma":[0.02445611,0.009342033,0.08526701,0.5632754,0.03066411,0.001434369,0.00006404905,7.066982e-7,0.00007614894,0.000009711559,0.2845484,0.0008620024],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06073942,0.9370314,0.00004925731,0.0000382583,0.00005102466,0.001001645,0.001058104,0.000003263885,0.00002765415],"genre_scores_gemma":[0.01635362,0.9823288,0.0009821353,0.00004647654,0.00006225898,0.00006758126,0.00003150369,0.00004186723,0.00008571221],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9662912,"threshold_uncertainty_score":0.6839954,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08069286411793578,"score_gpt":0.4205409682839081,"score_spread":0.3398481041659723,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}